Showing results (1-10 of 2,461) with videos related to
Sort By:
Pageof 247
Biopharmaceutics & Drug Disposition|January 1, 1984
Bioavailability studies with etodolac in dogs and manM Kraml, L Cosyns, D R Hicks, et al.Journal of Diabetes and Its Complications|January 1, 1994
Tolrestat pharmacokinetics in rat peripheral nerveD Dvornik, J Millen, D R Hicks, et al.Journal of Clinical Pharmacology|November 1, 1981
Comparative bioavailability of propranolol: twice-daily versus four times-daily administrationD Dvornik, M Kraml, J Dubuc, et al.Clinical Pharmacology and Therapeutics|October 1, 1984
Tolrestat kineticsD R Hicks, M Kraml, M N Cayen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeysM N Cayen, D R Hicks, E S Ferdinandi, et al.Clinical Biochemistry|February 1, 1977
A gas-liquid chromatographic method for the determination of butriptyline in serumH Bruderlein, M Kraml, D DvornikXenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1986
The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogsM N Cayen, R Gonzalez, E S Ferdinandi, et al.Therapeutic Drug Monitoring|January 1, 1984
Determination of tolrestat, a novel aldose reductase inhibitor, in serum and tissuesD R Hicks, M KramlClinical Pharmacology and Therapeutics|December 1, 1982
Propranolol dosage, plasma concentration, and beta blockadeJ F Mullane, J Kaufman, D Dvornik, et al.Journal of Pharmaceutical Sciences|March 1, 1983
Sensitive high-performance liquid chromatographic method for the determination of etodolac in serumL Cosyns, M Spain, M KramlPageof 247